# Amgen Inc: Form 8-K, filed Oct 27, 2026

- Company: [Amgen Inc](/companies/amgn.md) (CIK 318154)
- Form: 8-K
- Filed: 2026-10-27
- Accepted by EDGAR: Oct 26, 2026, 17:58 ET
- Period: 2026-10-26
- Accession: 0000318154-26-000144
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/318154/000031815426000144/amgn-20261026.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/318154/000031815426000144/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/318154/000031815426000144/amgn-20261026.htm

Filed Oct 27, 2026.
Source: SEC EDGAR, the filing index for accession 0000318154-26-000144. Last ingested by Listed: Nov 10, 2026, 06:19 ET. No prices; not investment advice.